The official blog of the Lung Institute.

Is It Okay to Vape with COPD?

6 Feb 2018
| Under COPD, Lifestyle, Smoking, Tips | Posted by | 2 Comments
Is It Okay to Vape with COPD

As of September 22, 2017, roughly 2.75 million people regularly smoke e-cigarettes, a habit commonly referred to as “vaping” since the nicotine is delivered via vapors. An additional 3.7 percent of the population admit to having at least tried them.

While some insist that e-cigarettes are safer alternatives to regular cigarettes, what does science say? And specifically, what does it say for those diagnosed with chronic obstructive pulmonary disease (COPD)?

Vaping and COPD

In October of 2017, the American Journal of Respiratory and Critical Care Medicine published a study conducted by the University of North Carolina Health Care that looked at this very issue.

A total of 44 people participated: 15 who smoked e-cigarettes, 14 who smoked regular cigarettes, and 15 who didn’t smoke at all. What did they find?

In regard to the participants who smoked e-cigarettes specifically, researchers found certain proteins in their airways that are known contributors to inflammatory lung diseases like COPD.

Worse yet, e-cigarette smokers also had some of the same negative effects as cigarette smokers. For instance, both had increases in biomarkers of oxidative stress typically associated with lung disease and their mucus secretions increased as well.

Previous studies have found similar negative results. For instance, one piece of research released in 2012 found that e-cigarettes increase airway resistance for as long as 10 minutes.

The Final Verdict

While results of just two studies aren’t necessarily strong enough to insist that vaping is not okay for those with COPD, the science is certainly leaning in this direction.

The Lung Institute does not recommend vaping for anyone, especially for anyone who suffers from a lung disease. In May 2016, the Food and Drug Administration (FDA) outlined regulations that extended its authority to electronic cigarettes and eliquids. The rules stated that any e-cigarette or vaping product released after Feb 15, 2007, would require the same expensive, lengthy FDA approval as regular smoking products.

Since they are a relatively new product, little testing has been completed and there are no long-term studies completed to reveal long-term effects of vaping. The lack of regulation allows e-cigarette ads to reach children. Studies show that e-cigarette ads reach more than 50 percent of 12-17-year old children, which some say ultimately promotes smoking, nicotine consumption and addictive behaviors.

Nicotine consumers must choose whether vaping is an acceptable alternative to quitting smoking. While vaping may help individuals quit smoking, once someone develops chronic lung disease such as COPD, emphysema or interstitial lung disease, inhaling anything other than clean air can lead to an exacerbation of lung disease.

Remember these points


If you or a loved one suffers from a chronic disease like COPD, emphysema, pulmonary fibrosis or other symptoms of lung disease, the Lung Institute offers a variety of adult stem cell treatment options. Contact us today at (800) 729-3065 or fill out the form to see if you qualify for stem cell therapy, and find out what stem cell therapy could mean for you.

Interested in our article on vaping and COPD? Share your thoughts and comments below.


  1. Lung Institute

    2 weeks ago


    Thank you for your comment. We reply to most all of the comments that people send in as long as they are regarding a lung disease and our treatments. I am not sure what comment you are referencing. We would be happy to view your comment again.


    The Lung Institute

  2. Linda Hopkins

    2 weeks ago

    You ask for comments, then remove them with no reply ? . . To this I say wassup wit dat ?

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.